Inspire Investing’s Cantel Medical Corporation CMD Stock Holding History

Inspire Investing’s Portfolio CMD Stock Details CMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-572	Closed	-$59K	–	812
2017 Q4	$59K	Buy	+572	New	+$57K	0.05%	365

Other funds holding CMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Diker Management New York $112M AUM 59.78% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Inspire Investing's CMD Position: Q1 2018 in Review

Inspire Investing sold out of Cantel Medical Corporation (CMD) in Q1 2018, closing a stake of 572 shares — an estimated $59K sold.

Inspire Investing first reported a position in CMD in Q4 2017 and held it in 1 quarter. The position peaked at $59K in Q4 2017. 270 funds tracked by Wall St. Rank hold CMD as of Q1 2018.

Inspire Investing reported no remaining Cantel Medical Corporation position as of Q1 2018 after selling out during the quarter.
Inspire Investing sold 572 Cantel Medical Corporation shares in Q1 2018, an estimated $59K.
Inspire Investing first reported a position in Cantel Medical Corporation in Q4 2017 and held it in 1 quarter.
Inspire Investing's Cantel Medical Corporation position peaked at $59K in Q4 2017.
270 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2018.

Based on Inspire Investing's 13F filing for Q1 2018, filed 13 Apr 2018.